ℹ️
🇬🇧
Search
Search for people relevant for "low-dose"
low-dose
Person
Class
Person
Publication
Programmes
prof. MUDr. Vladimír Maisnar Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
464 publications
Publications
publication
Monotherapy with low-dose thalidomide for relapsed or refractory multiple myeloma: better response rate with earlier treatment
2007 |
Publication without faculty affiliation
publication
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
publication
Standardized 18F-FDG PET/CT in patients with myeloma: joint recommendation of Czech Myeloma Group and Czech Society of Nuclear Medicine
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Standardization of PET/CT in patients with multiple myeloma – Joint recommendation of The Czech Myeloma Group and The Czech Society of Nuclear Medicine
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Diagnostika a léčba mnohočetného myelomu 2023. Doporučení České myelomové skupiny, Slovenské myelómové skupiny a Myelomové sekce České hematologické společnosti pro diagnostiku a léčbu mnohočetného myelomu
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
2023 |
Faculty of Medicine in Hradec Králové
publication
Aktuální stav laboratorní diagnostiky monoklonálních gamapatií : 1. část kapitoly
2023 |
Faculty of Medicine in Hradec Králové
Load more publications (454)
Loading network view...